Consortium Institutions
The three participating institutions in the Fred Hutch/University of Washington/Seattle Children's Cancer Consortium have a history of collaboration across the disciplines of basic, clinical and public health sciences. Together, we are fostering world-class, state-of-the-art research programs and providing excellent patient-centered care.
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center, formed in 1973, is one of the world's leading cancer research centers. Home of three Nobel laureates, Fred Hutch is an independent, nonprofit research institution dedicated to the development and advancement of biomedical technology to eliminate cancer and other potentially fatal diseases.
Fred Hutch scientists address basic science, early detection, treatment and cures, and cancer survivorship. Fred Hutch pioneered bone marrow transplantation for the treatment of blood cancers and is home to the nation’s first and largest cancer prevention program.
University of Washington
The UW Medicine healthcare system partners with Fred Hutch to provide world-class adult cancer treatment to patients in the state of Washington and beyond. Fred Hutch serves as the adult oncology unit for UW Medicine.
In addition to the clinical relationship between UW Medicine and Fred Hutch, many Consortium members have primary faculty appointments at the University of Washington (UW), primarily in the School of Medicine and School of Public Health. The UW School of Medicine, a top-ranked academic research institution and a leading teaching hospital for the Pacific Northwest region, has a mission of improving the health of the public by educating and empowering the next generation of physicians, researchers, and stewards of health. The UW School of Public Health’s mission is to solve today’s greatest public health challenges and co-create health equity with communities in the region and the world.
Seattle Children's
Seattle Children's Hospital and Research Institute offer a full range of care for cancer and blood disorders. In 2012, U.S. News & World Report ranked Children's Cancer Center 7th best in the country.
Children’s is internationally recognized for advancing discoveries in cancer, genetics, immunology, pathology, infectious disease, injury prevention and bioethics. Children’s also serves as the primary clinical, research, and teaching site for the Department of Pediatrics at the University of Washington School of Medicine.
Collaborations
The Consortium is the home of several Clinical Coordinating Centers and National Institutes of Health- supported Specialized Programs of Research Excellence (SPOREs) in cancer. These programs emphasize collaboration between laboratory and clinical scientists in planning and implementing research projects and sharing, managing, and analyzing data.
Fred Hutch Lung SPORE
The Fred Hutch Lung Specialized Project of Research Excellence (SPORE) brings together experts from across Fred Hutch and its partner organizations to fast-track the latest breakthroughs in its labs to patients and those at risk of developing lung cancer. The Lung SPORE has leveraged the strengths of its investigators and Fred Hutch to tackle three critical barriers precluding meaningful improvements in lung cancer survival rates: facilitation of pulmonary nodule evaluation for lung cancer early detection and screening, lack of effective therapies for small cell lung cancer (SCLC), and the sub-optimal response rates of non-small cell lung cancer (NSCLC) patients to novel immune-based therapies.
Institute of Translational Health Sciences
ITHS facilitates the translation of scientific discoveries into practice by supporting funded research through a range of resources and services. Programs include: expert consultations in biomedical informatics, biomedical statistics, and bioethics; research coordination and regulatory support; access to community-based research programs; and specialized resources such as technology development, therapeutic manufacturing, dedicated patient rooms and staff supporting clinical research. ITHS's Research Navigator is available for personalized guidance to our portfolio of services, educational programs, funding opportunities, and other research resources.
Office of Translational Research
The Office of Translational Research (OTR) is a multidisciplinary, multi-institutional effort between Fred Hutch Cancer Center, UW Medicine, and Seattle Children’s to bridge laboratory and patient care and provide the most precise treatment options for patients with cancers. OTR is committed to accelerating translational research through building bridges across disciplines to facilitate science and improve lives. With creativity, collaboration, and inclusivity, we connect diverse minds and break down barriers bringing us closer to a cancer-free world.
Specimen & Data Access Network
Launched in 2019, the Specimen & Data Access Network (SAN) is a Pacific Northwest based network of ten human health focused institutions dedicated to advancing patient-centered research. SAN accelerates research by enabling efficient access to specimens and data, an essential first step in the translational research lifecycle. Through a centralized, transparent process, the SAN coordinating center helps researchers quickly identify and request available resources across the region. SAN supports researchers through six core services: Access to Specimens, Access to Datasets, Data Management Support, Resource Management, Research Connections, and Regulatory Guidance.
Pacific Northwest Prostate Cancer SPORE
The Pacific Northwest Prostate Cancer Specialized Program of Research Excellence (SPORE), one of eight Prostate Cancer SPOREs in the nation, represents a coordinated effort between Fred Hutch, University of Washington and its affiliated institutions, the University of British Columbia and the Prostate Centre of Vancouver General Hospital, and Oregon Health and Sciences University, working together toward a common goal of reducing morbidity and mortality associated with prostate cancer.